SOPHiA GENETICS SA (SOPH)

About SOPHiA GENETICS SA

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.

Headquarters: Rolle, US · Employees: 415 · Website: https://www.sophiagenetics.com

Supply-chain relationships for SOPH

• ILLUMINA, INC. (ILMN) — partner

Frequently asked questions about SOPHiA GENETICS SA (SOPH)

What is SOPHiA GENETICS SA (SOPH)?

SOPHiA GENETICS SA (SOPH) is a publicly traded company in the Services-Computer Processing & Data Preparation sector (Health Information Services), listed on Nasdaq. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.

Who are SOPHiA GENETICS SA's key suppliers and customers?

Macroplane tracks SOPHiA GENETICS SA's (SOPH) supply chain. Tracked supply-chain partners include ILLUMINA, INC. (ILMN).